Form 8-K - Current report:
SEC Accession No. 0001178879-19-000072
Filing Date
2019-12-19
Accepted
2019-12-19 16:55:54
Documents
15
Period of Report
2019-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k121919.htm   iXBRL 8-K 39606
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 15218
  Complete submission text file 0001178879-19-000072.txt   200603

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20191213.xsd EX-101.SCH 4612
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20191213_cal.xml EX-101.CAL 640
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20191213_def.xml EX-101.DEF 1490
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20191213_lab.xml EX-101.LAB 26138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20191213_pre.xml EX-101.PRE 13596
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k121919_htm.xml XML 4324
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 191296369
SIC: 2834 Pharmaceutical Preparations